Equities

Jin Medical International Ltd

ZJYL:NAQ

Jin Medical International Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.74
  • Today's Change0.00 / 0.00%
  • Shares traded122.07k
  • 1 Year change+857.74%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jin Medical International Ltd is a China-based holding company. The Company, through its wholly-owned subsidiarie, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company’s products are sold to distributors in both China and in the oversea markets.

  • Revenue in USD (TTM)19.82m
  • Net income in USD2.88m
  • Incorporated2020
  • Employees245.00
  • Location
    Jin Medical International LtdNo. 33 Lingxiang Road, Wujin DistrictCHANGZHOU 213149ChinaCHN
  • Phone+86 51 989607972
  • Websitehttp://ir.zhjmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pulmonx Corp72.99m-58.73m281.41m279.00--2.55--3.86-1.54-1.541.912.850.3991.147.81261,627.20-32.11-26.27-35.87-28.9774.3171.95-80.46-93.766.14--0.252--27.9827.98-3.26--20.62--
AxoGen Inc163.73m-21.28m298.50m426.00--3.20--1.82-0.4943-0.49433.802.130.87091.497.04384,333.30-11.32-13.92-12.82-15.8478.3479.74-13.00-20.282.23-8.760.3346--14.7413.6324.98--17.70--
Tactile Systems Technology Inc276.67m28.19m302.49m992.0010.761.568.711.091.181.1811.708.141.016.776.05278,896.2010.300.901512.181.0949.9849.1010.190.83093.63--0.1280.0011.2013.81259.6033.91-23.62--
Zynex Inc188.68m8.17m322.52m1.10k44.899.9325.501.710.22610.22615.391.021.592.526.56171,530.006.8914.588.4117.5280.2279.624.3310.442.877.240.6381--16.5442.01-42.910.37412.19--
Sight Sciences Inc81.50m-54.75m326.40m214.00--2.98--4.01-1.12-1.121.672.200.46281.665.09380,822.40-31.09-38.78-33.65-42.2085.7380.74-67.18-105.1412.42-14.760.2358--13.6360.8435.59--6.77--
Nevro Corp430.75m-82.59m343.41m1.22k--1.23--0.7973-2.28-2.2811.907.590.7361.146.04354,523.50-14.11-13.64-16.06-16.6868.9468.54-19.17-20.675.57--0.4354--4.631.88-3,172.74--0.9012--
Treace Medical Concepts Inc196.03m-54.75m364.61m516.00--2.88--1.86-0.8885-0.88853.182.040.7971.287.07379,905.00-22.26---25.98--80.99---27.93--3.22--0.2958--31.92---15.68------
Jin Medical International Ltd19.82m2.88m428.94m245.00138.1717.82138.1821.640.01980.01980.14140.15380.73632.214.7780,903.9210.6912.8114.6820.9234.2333.5814.5214.602.92--0.14640.003.29-1.076.34-4.80-9.50--
ZimVie Inc455.22m-51.16m454.36m2.60k--1.17--0.9981-1.92-14.0117.1114.240.32991.093.73175,085.40-3.71---4.28--63.0565.51-11.24-8.732.23-0.3430.5673---1.26-16.08-19.50---23.70--
MaxCyte Inc44.05m-36.57m468.36m143.00--2.07--10.63-0.3532-0.35320.42532.170.16330.4635.77308,067.80-13.56-13.18-14.36-14.3388.3288.79-83.01-62.9612.37--0.00---6.7219.89-60.89--39.13--
Nano-X Imaging Ltd10.01m-61.26m483.11m164.00--2.61--48.26-1.08-1.080.17553.200.045--7.2861,042.68-27.54-30.98-30.10-35.10-71.15---611.89-1,527.245.59--0.0177--15.47--46.33--114.35--
Pacific Biosciences of California Inc200.43m-296.90m487.52m796.00--0.751--2.43-1.14-1.140.76952.380.11242.216.69251,797.70-16.65-16.19-18.40-17.8128.8137.35-148.13-136.218.36-21.840.5791--56.2920.592.39--36.68--
Orthofix Medical Inc760.05m-126.48m515.28m1.63k--0.9006--0.678-3.40-3.4020.4215.240.83381.166.36465,143.80-13.87-8.88-16.48-10.9666.2072.37-16.64-9.281.19-8.380.194--62.0610.51-666.60--30.01--
Bioventus Inc522.74m-21.65m532.62m995.00--3.1020.871.02-0.3438-0.34388.302.160.62171.954.28538,910.30-3.23-5.52-4.47-7.2765.5568.25-5.20-10.940.97451.030.6428--0.04459.936.91--23.51--
Iradimed Corp67.69m17.92m537.85m148.0030.187.0728.717.951.411.415.316.010.82731.675.51457,333.4021.9113.1624.0214.5876.5776.5526.4821.467.77--0.0068.1323.0016.5934.0222.2297.77--
SI-Bone Inc144.05m-43.12m578.93m344.00--3.49--4.02-1.08-1.083.614.030.77281.626.44418,735.50-23.13-27.88-25.72-30.9478.1085.03-29.93-51.098.75--0.1791--30.5220.1929.25--52.62--
Data as of May 31 2024. Currency figures normalised to Jin Medical International Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.48%Per cent of shares held by top holders
HolderShares% Held
Marshall Wace LLPas of 31 Mar 2024191.08k0.12%
Invesco Capital Management LLCas of 31 Mar 2024141.65k0.09%
Geode Capital Management LLCas of 31 Mar 2024106.54k0.07%
Millennium Management LLCas of 31 Mar 202476.40k0.05%
Winton Capital Management Ltd.as of 31 Mar 202472.28k0.05%
XTX Markets LLCas of 31 Mar 202440.13k0.03%
Jane Street Capital LLCas of 31 Mar 202435.17k0.02%
The Vanguard Group, Inc.as of 31 Mar 202431.11k0.02%
Schonfeld Strategic Advisors LLCas of 31 Mar 202429.90k0.02%
JPMorgan Securities LLC (Investment Management)as of 31 Mar 202421.14k0.01%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.